GLP-1 coverage in Newfoundland and Labrador

The Newfoundland and Labrador Prescription Drug Program (NLPDP) is made up of several income-tested and category-based plans, including coverage streams for residents without private insurance and separate plans for seniors and people receiving income support. Which plan applies, and the resulting cost-sharing, depends on household income and circumstance.

GLP-1 medications such as Ozempic can be covered under NLPDP when prescribed for type 2 diabetes and approved through the program's Special Authorization process for restricted-listing drugs, which requires a prescriber to document that specific clinical criteria are met.

NLPDP's Special Authorization approvals for semaglutide and tirzepatide products are tied to the diabetes indication. A prescription for Wegovy, Saxenda, or an off-label weight-loss use of a diabetes-approved GLP-1 doesn't meet the program's criteria and isn't reimbursed under any NLPDP plan.

This is consistent across Canada: no provincial public drug plan currently covers a GLP-1 prescribed specifically for weight management. Because Special Authorization criteria are reviewed periodically, confirm current rules directly with NLPDP rather than assuming a past denial still applies.

For residents without applicable NLPDP or private coverage, Costco Pharmacy is generally the lowest-cost dispensing option nationally, with no membership required at the pharmacy counter, though location access can be more limited in Newfoundland and Labrador than in larger provinces. Generic semaglutide, available since the May 2026 Apotex and Dr. Reddy's launch, runs roughly $88 to $99/mo nationally; province-specific Costco pricing here hasn't been independently verified.

Brand-name pricing runs considerably higher at retail pharmacies: Ozempic $250-$310/mo, Wegovy $400-$570/mo, Mounjaro $280-$550/mo, Zepbound $435-$550/mo. About 31% of employer private plans now cover GLP-1s for weight loss, and manufacturer savings cards can reduce brand costs for those with existing private insurance. Compounded GLP-1 products remain illegal in Canada.